PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Clinical trials for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT explained in plain language.
Never miss a new study
Get alerted when new PROSTATIC NEOPLASMS, CASTRATION-RESISTANT trials appear
Sign up with your email to follow new studies for PROSTATIC NEOPLASMS, CASTRATION-RESISTANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-World data may reveal Pluvicto's true impact on advanced prostate cancer survival
Disease control Not yet recruitingThis study looks at how effective the drug Pluvicto (177Lu-PSMA-617) is in treating men with a type of advanced prostate cancer that no longer responds to hormone therapy and has spread to other parts of the body. Researchers will analyze medical records from over 1,000 patients …
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
AI could predict when prostate cancer becomes resistant to treatment
Diagnosis Not yet recruitingThis study tests an artificial intelligence (AI) model that uses images from prostate biopsies to predict when prostate cancer will become resistant to hormone therapy. Researchers will enroll 150 patients with intermediate- to high-risk prostate cancer who are starting hormone t…
Matched conditions: PROSTATIC NEOPLASMS, CASTRATION-RESISTANT
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC